I recommend a **federated** agentic operating model: each executive owns a domain platform, all platforms share an enterprise architecture and control plane, and every platform improves through a governed evidence-to-change loop.

Do not assign one framework to each executive and treat the mapping as complete. Each platform needs several complementary elements:

1. Governance: who can decide, approve, and accept risk.
2. Domain practices: how the function performs its work.
3. Architecture: capabilities, information, services, and dependencies.
4. Operating model: workflows, service levels, ownership, and recovery.
5. Assurance: how correctness and control effectiveness are verified.
6. Improvement: how changes are proposed, evaluated, promoted, and reversed.

Two refinements to your starting model:

- TOGAF should support enterprise-wide architecture, not only the CTO’s technology platform. Its scope includes business, data, application, and technology architecture. [togaf.visual-paradigm](https://togaf.visual-paradigm.com/2025/03/04/mastering-enterprise-architecture-a-comprehensive-guide-to-the-togaf-framework-and-its-key-concepts/)
- Separate CBO’s business-model and commercial platform from COO’s execution and operational platform. Otherwise both roles become owners of “how the business works.”

The tables below are my proposed operating-model design. Framework assignments are recommendations—not requirements imposed by the frameworks themselves.

## 1. Core C-suite: platforms, frameworks, and capabilities

### Organization, business, product, and operations

| Executive / platform | Recommended frameworks and models | Agentic platform capabilities | Principal artifacts and measures |
|---|---|---|---|
| CEO — Organization and strategy platform | Balanced Scorecard and strategy maps; OKRs for bounded objectives; enterprise operating-model design; COSO ERM for risk-informed strategy; COBIT for governance of information and technology | Synthesize organizational state; compare strategic scenarios; coordinate executive objectives; identify dependencies; propose portfolio allocation; route reserved decisions; monitor outcomes | Strategy map; objective register; authority matrix; initiative portfolio; enterprise scorecard. Measure realized benefits, strategic progress, unresolved dependencies, and governance exceptions |
| CBO — Business architecture and commercial platform | BIZBOK for capabilities and value streams; Business Model Canvas / Value Proposition Canvas; scenario planning; commercial experiment design | Map value creation; identify customer segments and economic buyers; assess markets and partnerships; build business cases; test commercial assumptions; connect proposed commitments to delivery capability | Business capability map; value streams; business-model hypotheses; opportunity and partnership registers. Measure validated demand, realized contribution, partner benefit, and forecast calibration |
| CPO — Product and experience platform | PDMA Body of Knowledge as the domain foundation; Jobs to Be Done; continuous discovery; outcome-based roadmaps; product lifecycle management; specification-driven delivery | Synthesize authorized customer evidence; discover problems; propose priorities; maintain specifications; coordinate experiments; assess usability and accessibility; track adoption and retirement | Opportunity repository; outcome roadmap; versioned specifications; experiment register. Measure successful customer outcomes, adoption, reliability, support burden, and cost per successful outcome |
| COO — Operations and service-delivery platform | APQC Process Classification Framework for process inventory; BPMN for process models; ITIL for service management; Lean / Theory of Constraints for flow; SRE practices for technical service reliability | Coordinate approved work; manage queues and dependencies; forecast capacity; detect bottlenecks; execute bounded runbooks; coordinate incidents; reconcile completion; improve end-to-end delivery | Process and service catalogs; operating plans; runbooks; capacity plans; incident records. Measure verified completion, cycle time, rework, service reliability, and recovery |

PDMA’s body of knowledge explicitly spans strategy, portfolio, process, design and development, market research, and teams—making it a stronger CPO foundation than treating Agile delivery as the complete product discipline. [pdma](https://www.pdma.org/page/npdp-bok-third-edition)

For architecture and governance, keep the scopes distinct: TOGAF supplies architecture methods; COBIT addresses governance and management of enterprise information and technology; ITIL supports service-management practices. They are complementary, not substitutes. [coe.qualiware](https://coe.qualiware.com/resources/togaf/9-1/part7-capabilityframework/architecture-governance/)

### Technology, data, AI, finance, and legal

| Executive / platform | Recommended frameworks and models | Agentic platform capabilities | Principal artifacts and measures |
|---|---|---|---|
| CTO — Technology and engineering platform | TOGAF for architecture development and governance; ArchiMate / C4 for complementary views; domain-driven design; secure SDLC; SRE; software supply-chain controls | Assess architecture; generate bounded implementation plans; coordinate coding and testing; analyze dependencies; propose migrations; manage technical debt; prepare release evidence | Architecture repository; ADRs; service catalog; dependency graph; delivery and recovery evidence. Measure reliability, change failure, maintainability, security exposure, and delivery lead time |
| CDO — Data and knowledge platform | DAMA-DMBOK as the foundation; DCAM as an optional capability assessment; data contracts; domain-oriented data products; provenance and semantic modeling | Ingest and classify data; maintain metadata; detect quality failures; curate knowledge; manage lineage; enforce permitted use through control services; assess retrieval quality | Catalog; glossary; lineage graph; data contracts; quality rules; evidence repository. Measure freshness, completeness, reconciliation accuracy, provenance coverage, and retrieval correctness |
| CAIO — AI, agent, and improvement platform | NIST AI RMF; ISO/IEC 42001 as a management-system reference; AI lifecycle management; MLOps / LLMOps / AgentOps; protected evaluation and champion–challenger methods | Maintain model and agent inventories; describe capabilities; route tasks; manage bounded delegation; evaluate models and tools; propose improvements; coordinate isolated candidates | Agent/model registry; evaluation suites; autonomy profiles; improvement portfolio; promotion records. Measure verified task success, calibration, boundary violations, cost, and net improvement |
| CFO — Finance and capital platform | COSO Internal Control; approved accounting basis such as GAAP or IFRS where applicable; FP&A; activity-based costing; FinOps; investment appraisal and scenario analysis | Reconcile financial evidence; forecast liquidity; attribute agent and compute costs; monitor commitments; assess investments; identify anomalies; prepare financial reports | Budgets; commitment ledger; forecasts; unit-economics models; investment cases; control exceptions. Measure reconciliation quality, liquidity, forecast error, and realized investment benefit |
| CLO — Legal and obligation platform | CLOC Core 12 for legal operations; contract lifecycle management; matter management; jurisdiction-specific legal playbooks; preservation and information-governance procedures | Structure legal intake; verify research sources; compare contracts; extract candidate obligations; route specialist review; track deadlines; coordinate approved preservation | Matter register; contract and obligation register; verified research; approvals; preservation records. Measure material omissions, obligation completion, research integrity, and appropriate escalation |

DAMA-DMBOK provides the domain foundation for building and governing data programs; it should be translated into concrete ownership, services, controls, and evidence rather than adopted only as a vocabulary. [dama](https://dama.org/learning-resources/dama-data-management-body-of-knowledge-dmbok/)

NIST AI RMF is voluntary guidance covering AI risk across design, development, use, and evaluation. Its Govern, Map, Measure, and Manage functions are useful across every agentic platform—not only CAIO’s platform. [nist](https://www.nist.gov/itl/ai-risk-management-framework)

CLOC Core 12 is especially suitable for CLO’s operational platform: it covers information and knowledge governance, service delivery, practice operations, technology, financial management, and organizational development. It is not a substitute for substantive legal advice. [cloc](https://cloc.org/cloc-core-12/)

## 2. Additional functions a research-and-trading platform needs

Your proposed executive set covers enterprise management, but it does not yet explicitly allocate investment decisions, independent risk, or scientific research quality.

I would add the following functions. They do not all need separate executive agents initially.

| Role / platform | Recommended models and frameworks | Agentic capabilities | Critical separation |
|---|---|---|---|
| Chief Investment Officer — Investment and portfolio platform | Investment Policy Statement; portfolio construction; asset allocation; factor and scenario analysis; performance attribution | Translate approved mandates into model portfolios; compare allocations; propose rebalancing; analyze exposure; generate investment decision packets | CIO owns investment proposals; CFO owns corporate finance. Neither automatically owns independent risk approval |
| Chief Research Officer / Chief Scientist — Research platform | Scientific method; preregistered hypotheses; reproducible computational research; experiment tracking; systematic evidence review | Generate hypotheses; assemble evidence; run controlled experiments; reproduce findings; assess contradictory results | Research discovery must remain separate from final strategy validation |
| Chief Risk Officer — Enterprise, investment, and model-risk platform | COSO ERM; ISO 31000; model-risk-management practices; stress testing; scenario analysis | Aggregate exposures; challenge assumptions; assess concentration and liquidity; monitor limits; independently evaluate model misuse | Direct escalation to human governance; protected independence from revenue and investment functions |
| CISO — Security and trust platform | NIST CSF; ISO/IEC 27001; zero-trust architecture; threat modeling; secure development practices | Analyze threats; assess permissions; detect suspicious agent behavior; coordinate authorized containment; validate security controls | Security findings cannot be overruled by an agent seeking release or increased autonomy |
| Chief Compliance Officer — Compliance and market-integrity platform | Applicability register; control mapping; compliance monitoring; surveillance procedures; approved recordkeeping policies | Monitor obligations; identify exceptions; inspect communications and order patterns within authorized scope; assemble evidence | Compliance assessment is distinct from CLO’s legal interpretation and COO’s execution |
| Chief Quality / Evaluation Officer — Independent assurance platform | Risk-based testing; reproducibility; model validation; adversarial evaluation; quality-management practices | Maintain protected tests; evaluate candidates; verify claims; detect regression and evidence contamination | Candidate builders must not control final passing criteria |
| Chief People / Workforce Officer — Human–agent workforce platform | Competency models; organizational design; skills-based planning; training and change management | Map competencies; plan review capacity; coordinate training; assess human–agent handoffs | Employment decisions remain with authorized humans |

Banking model-risk guidance such as SR 11-7 provides a useful reference for development discipline, validation, and governance. Its stated scope is banking organizations; use it as a design reference unless counsel determines a specific supervisory requirement applies. [federalreserve](https://www.federalreserve.gov/boarddocs/srletters/2011/sr1107a1.pdf)

For a lean starting organization, I would combine:

- CBO with Revenue and Marketing coordination.
- COO with Customer Success coordination.
- CRO with model-risk coordination, but preserve independent evaluation.
- CDO with research-data stewardship, while keeping scientific judgment under the research function.

Do not combine strategy development, independent validation, and live-trading authorization into one unchecked agent.

## 3. What “all platforms must be agentic” should mean

I would define agentic as:

> A platform can interpret approved goals, gather authorized evidence, plan and delegate bounded work, use tools, evaluate outcomes, and propose its next action—while deterministic systems enforce authority and exact rules.

It should not mean replacing every service with an LLM.

### A common architecture for every platform

| Layer | Common capabilities | Example |
|---|---|---|
| Domain interface | Workbench, API, events, structured intake | CFO investment request; CLO contract intake |
| Domain knowledge | Policies, glossary, ontology, approved evidence | Accounting definitions; contract playbooks |
| Agent reasoning | Analysis, planning, synthesis, tool selection | Compare investment alternatives |
| Workflow execution | Durable state, tasks, dependencies, approvals, cancellation | Wait for counsel or risk approval |
| Domain services | Deterministic calculations and state transitions | Ledger posting; exposure calculation |
| Control plane | Identity, tenant scope, budget, approval binding, tool permissions | Prevent unauthorized live orders |
| Evidence plane | Provenance, versions, decisions, evaluation results | Reconstruct why a strategy was promoted |
| Improvement plane | Candidate generation, sandboxing, independent tests, promotion | Evaluate a new research workflow |

This gives every platform an agentic interface and improvement capability without allowing model reasoning to become the final authority for financial arithmetic, authorization, or transaction state.

The workflow-execution layer is realized as one product: the **Generic workflow capability** (#3700) — the one workflow engine as a shared Technology Platform product (owner: Technology Platform, the CTO shared runtime). Its capabilities, in this model's own terms, are durable state, tasks, dependencies, approvals, and cancellation; its surfaces are the stage operations, the job plane, the stage chains, and the run records. Every domain platform consumes the same engine — there is no per-platform engine. Family adoption onto the product is tracked separately (#3549, #3550–#3555) and tenant instantiation separately (#3687); neither is absorbed into the product.

### One enterprise architecture, not ten isolated stacks

Treat these as logical platforms with explicit contracts—not necessarily separate deployments.

For example:

- CTO provides shared runtime and engineering infrastructure.
- CDO provides shared data and knowledge services.
- CAIO provides shared agent lifecycle and evaluation infrastructure.
- Each executive owns domain outcomes, workflows, policies, and acceptance criteria.
- Control functions retain independent reporting and protected decision rights.

This avoids creating a separate registry, memory system, workflow engine, and policy service for every executive.

## 4. The research-and-trading value stream

For your intended product, the central organizing structure should be an end-to-end value stream—not the executive org chart.

```text
Approved investment mandate
            ↓
Licensed, point-in-time data
            ↓
Research question and hypothesis
            ↓
Reproducible experiment
            ↓
Independent strategy validation
            ↓
Portfolio construction and risk assessment
            ↓
Paper / shadow operation
            ↓
Authorized limited live deployment
            ↓
Order and execution controls
            ↓
Position, cash, and transaction reconciliation
            ↓
Performance attribution and incident review
            ↓
Next research or retirement decision
```

### Assign ownership across that stream

| Stage | Lead | Required partners / challenge |
|---|---|---|
| Investment mandate | Human investment owner / CIO | CRO, CLO, CFO |
| Data acquisition and normalization | CDO | Research, CLO, CISO |
| Hypothesis and experiment | Research | CDO, CAIO, CTO |
| Independent validation | Evaluation / model-risk function | Research provides artifacts, not final approval |
| Portfolio and sizing proposal | CIO | CRO, CFO for relevant financial context |
| Paper and shadow operation | CIO + COO | CTO, Evaluation, CRO |
| Live authorization | Designated human authority | Required Risk, Compliance, and operational approvals |
| Execution and reconciliation | COO / trading operations | CTO, CIO, CDO |
| Performance review | CIO + Research | Independent Risk and Evaluation |
| Commercialization | CBO + CPO | CLO, Finance, Operations |

Corporate cash management and customer or strategy investment capital must remain distinct. Likewise, a successful product experiment is not proof that an investment strategy is sound.

### Trading-specific controls I would make foundational

- Point-in-time datasets, including when information became available.
- Explicit treatment of revisions, delistings, and corporate actions.
- Research trial history, including unsuccessful candidates.
- Out-of-sample and forward-testing protocols.
- Costs, slippage, liquidity, and capacity assumptions.
- Portfolio-level exposure and concentration limits.
- Stale-data and stale-price rejection.
- Deterministic pre-trade checks.
- Independent kill switches and controlled restart.
- Idempotent order submission and unknown-outcome reconciliation.
- Verified positions, cash, fills, and fees.
- Separation of research, paper, shadow, and live environments.

These are proposed engineering and governance requirements, not a determination of your regulatory obligations. As an example of why applicability matters, SEC Rule 15c3-5 imposes market-access controls on covered broker-dealers; it is not automatically a universal obligation for every research application. [sec](https://www.sec.gov/files/rules/final/2011/34-64748fr.pdf)

## 5. A governed RSI model across every platform

Use one common improvement protocol, with domain-specific evidence.

```text
Observation
→ diagnosis
→ hypothesis
→ bounded candidate
→ isolated evaluation
→ independent challenge
→ authorized promotion
→ monitored adoption
→ retain, revise, reverse, or retire
```

| Platform | Example candidate | What must remain protected |
|---|---|---|
| Organization | Better portfolio prioritization | Approved purpose and reserved decisions |
| Business | Improved opportunity qualification | Truthful evidence and commercial authority |
| Product | Better research-to-decision workspace | Customer permissions and release criteria |
| Operations | Improved task scheduling | Tenant fairness, budgets, and recovery |
| Technology | New execution architecture | Security and reliability gates |
| Data | Better entity resolution | Provenance and permitted data use |
| AI / agents | New planner or tool-routing policy | Protected evaluations and privilege boundaries |
| Finance | Better cost attribution | Accounting integrity and exact calculations |
| Legal | Better obligation extraction | Confidentiality and qualified review |
| Research | Better hypothesis selection | Holdouts, trial history, and reproducibility |
| Investment | Revised allocation method | Mandate, risk limits, and deployment authorization |

Distinguish three kinds of change:

1. Execution adaptation within an approved workflow.
2. Reusable capability improvement.
3. Governance or evaluation-system change.

The third requires a separate, human-governed approval path. An agent must not improve its reported performance by changing how success is judged.

## 6. Other approaches I strongly recommend

### A. Build a shared enterprise metamodel

Use consistent objects across all platforms:

```text
Objective → Value stream → Capability → Product/service
         → Process → Agent/tool → Data → Control
         → Evidence → Decision → Outcome
```

Add research-and-trading objects:

```text
Mandate → Hypothesis → Dataset snapshot → Experiment
        → Strategy version → Validation → Portfolio
        → Order → Fill → Position → Attribution
```

This enables questions such as:

> Which strategies depend on this dataset, which customer products expose them, which controls were evaluated, and who authorized deployment?

A knowledge graph can represent these relationships, but it should not replace authoritative transactional records.

### B. Turn frameworks into executable controls

Do not stop at “we follow TOGAF, DMBOK, and NIST.”

For each selected practice, record:

| Field | Example |
|---|---|
| Intended outcome | No strategy enters live operation without approved validation |
| Owner | Investment owner |
| Enforcement | Deployment admission service |
| Required evidence | Dataset, code, model, evaluation, and approval versions |
| Test | Attempt deployment with missing or stale approval |
| Monitoring | Detect bypass attempts and expired authorization |
| Exception path | Explicit human decision with scope and expiry |

This is more useful than creating large framework checklists disconnected from runtime behavior.

### C. Use research decision packets as the unit of value

The platform should produce inspectable decisions, not just fluent research reports.

A decision packet should contain:

- Question and approved mandate.
- Evidence and provenance.
- Hypothesis and alternatives.
- Reproducible results.
- Limitations and contradictory findings.
- Portfolio and risk implications.
- Proposed action or explicit “no action.”
- Required approvals.
- Monitoring and invalidation conditions.

### D. Separate three portfolios

Maintain distinct portfolios for:

1. Product investment: what customers need.
2. Research investment: which uncertainties to investigate.
3. Trading investment: where authorized capital is exposed.

They compete for resources but have different success criteria. Combining them into one “ROI score” can hide important trade-offs.

### E. Define “world’s best” through evidence

I would evaluate the ambition using a balanced scorecard:

| Dimension | Demonstration of excellence |
|---|---|
| Research quality | Findings reproduce and survive independent challenge |
| Decision quality | Recommendations distinguish evidence, assumptions, and uncertainty |
| Trading quality | Results remain useful after costs, risk, liquidity, and capacity constraints |
| Trust | Users can inspect, correct, approve, and stop consequential work |
| Reliability | Recovery and reconciliation work under failure |
| Economics | Cost per verified useful outcome is sustainable |
| Governance | Privileges, budgets, and decisions remain enforceable |
| Improvement | Promoted changes produce independently verified net benefit |

No architecture, agent count, framework adoption, or backtest establishes future trading profitability or ASI.

## 7. Implementation order

| Phase | Build first | Exit evidence |
|---|---|---|
| 1 — Governed research | Mandates, licensed data, provenance, research workbench, read-only agents | A decision packet can be reproduced |
| 2 — Independent evaluation | Protected tests, model inventory, experiment history, challenger review | Unsupported candidates are reliably rejected |
| 3 — Portfolio simulation | Portfolio construction, risk analytics, realistic simulation | Results and assumptions reconcile |
| 4 — Paper and shadow operation | Durable workflows, simulated orders, live-data observation, recovery | Interruptions and uncertain outcomes are handled correctly |
| 5 — Limited live operation | Scoped authority, pre-trade controls, kill switches, reconciliation | Approved exposure limits remain enforced |
| 6 — Cross-platform RSI | Bounded improvement portfolios and controlled promotion | Net improvements persist without weakening controls |

My central recommendation is to build one agentic research-and-trading operating system with federated domain ownership—not a collection of executive personas with independent tool access. The executive platforms should align around shared value streams, shared evidence, and enforceable boundaries.
